Opportunity Information: Apply for PA 18 507

The NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant opportunity titled "Effects of In Utero Alcohol Exposure on Adult Health and Disease" (Funding Opportunity Number PA-18-507) supports R01 research projects that explore how alcohol exposure during pregnancy can shape health risks much later in life. The scientific premise is rooted in the Developmental Origins of Health and Disease (DOHaD) framework, which argues that conditions in the womb can trigger fetal adaptations that may be helpful for short-term survival but increase susceptibility to disease in childhood, adolescence, or adulthood. In practical terms, this FOA is looking for studies that treat prenatal alcohol exposure not only as a cause of early developmental problems, but also as a potential contributor to chronic diseases and long-term health conditions that may not emerge until decades later.

The FOA emphasizes three main research directions. First, it encourages researchers to use and extend existing prospective birth cohorts to better define how maternal alcohol consumption fits into the DOHaD process. This means taking advantage of cohorts that already have prenatal exposure data, biospecimens, and follow-up health information across the lifespan, and then analyzing whether and how prenatal alcohol exposure predicts later outcomes. Second, it calls for mechanistic research that digs into the biological, cellular, and molecular pathways by which gestational alcohol exposure might alter long-term physiology. This could include work on metabolic programming, cardiovascular function, immune and inflammatory regulation, endocrine signaling, neurodevelopmental trajectories tied to later disease vulnerability, epigenetic modifications, organ development, or other durable changes that connect prenatal exposure to adult pathology. Third, the FOA seeks biomarker discovery and validation studies aimed at identifying measurable indicators of alcohol exposure during gestation that could help predict disease susceptibility later in life among exposed offspring. The underlying idea is to move toward earlier detection and risk stratification, potentially enabling prevention or targeted monitoring long before chronic disease becomes clinically obvious.

Because the mechanism is an R01, the program is geared toward substantial, hypothesis-driven projects that can generate high-impact, generalizable findings. The FOA is labeled "Clinical Trial Optional," meaning applicants may propose clinical trials if appropriate, but they are not required to do so; both observational human studies and mechanistic biomedical studies can fit, as long as the central focus is on prenatal alcohol exposure and later-life health and disease risk. Overall, NIAAA is signaling interest in work that connects prenatal exposure to real-world adult outcomes, clarifies causal and biological pathways, and produces tools (like biomarkers) that could eventually support screening, prevention, or intervention strategies.

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants listed for the opportunity include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those categories); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based and community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and foreign (non-U.S.) entities.

Administrative details provided in the posting indicate it is a discretionary grant in the health funding area (CFDA 93.273) administered under the National Institutes of Health. The opportunity was created on December 18, 2017, and the original closing date listed is January 7, 2021. The award ceiling and expected number of awards are not specified in the provided summary, which is common for some NIH FOAs where funding decisions depend on application volume, merit, and available appropriations. The main takeaway is that this FOA is designed to spur rigorous, forward-looking research that links prenatal alcohol exposure to adult chronic disease risk, using a mix of cohort-based human research, mechanistic science, and biomarker development to strengthen the evidence base for a fetal origin contribution to later-life health outcomes influenced by maternal alcohol use.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
  • This funding opportunity was created on 2017-12-18.
  • Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 18 507

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Conduct post-fire bird surveys at Bandelier National Monument

Previous opportunity: Biotechnology Risk Assessment Grants Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 18 507

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 18 507) also looked into and applied for these:

Funding Opportunity
Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 025

Funding Number: RFA AG 18 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) Apply for PAR 18 522

Funding Number: PAR 18 522
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional) Apply for PA 18 508

Funding Number: PA 18 508
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional) Apply for PAR 18 543

Funding Number: PAR 18 543
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) Apply for PAR 18 534

Funding Number: PAR 18 534
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed) Apply for PAR 18 516

Funding Number: PAR 18 516
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) Apply for PAR 18 521

Funding Number: PAR 18 521
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 525

Funding Number: PA 18 525
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 18 523

Funding Number: PAR 18 523
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed) Apply for PAR 18 519

Funding Number: PAR 18 519
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional) Apply for PAR 18 542

Funding Number: PAR 18 542
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional) Apply for PAR 18 528

Funding Number: PAR 18 528
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional) Apply for PAR 18 533

Funding Number: PAR 18 533
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 022

Funding Number: RFA AG 18 022
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed) Apply for PAR 18 524

Funding Number: PAR 18 524
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required Apply for PAR 18 547

Funding Number: PAR 18 547
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional) Apply for PAR 18 538

Funding Number: PAR 18 538
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional) Apply for PAR 18 544

Funding Number: PAR 18 544
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional) Apply for PAR 18 548

Funding Number: PAR 18 548
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional) Apply for PAR 18 549

Funding Number: PAR 18 549
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 507", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: